Programmed cell death protein 1 — Drug Target

All drugs that target Programmed cell death protein 1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Programmed Death Receptor-1 Blocking Antibody [EPC]

Marketed (4)

• Opdivo · Bristol-Myers Squibb · Programmed Death Receptor-1 Blocking Antibody [EPC] · Oncology
  Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells.
• ZYNYZ · INCYTE CORP · Programmed Death Receptor-1 Blocking Antibody [EPC] · Oncology
• Pembrolizuma · Memorial Sloan Kettering Cancer Center · Oncology
• Zynyz · Incyte Corp · Programmed Death Receptor-1 Blocking Antibody [EPC] · Oncology
  Zynyz works by blocking the PD-1 receptor on immune cells, allowing them to recognize and attack cancer cells.